## Abstract SSR180575 (7‐chloro‐__N__,__N,__5‐trimethyl‐4‐oxo‐3‐phenyl‐3,5‐dihydro‐4__H__‐pyridazino[4,5‐__b__]indole‐1‐acetamide) is the lead compound of an original pyridazinoindole series of potent and highly selective TSPO (peripheral benzodiazepine receptor) ligands. Isotopic labeling of SSR18
A 11C-Methyl stannane (5-[11C]methyl-1-aza-5-stanna-bicyclo[3.3.3]undecane) for use in palladium-mediated [11C]C–C bond forming reactions with organohalides
✍ Scribed by Tobias Forngren; Linda Samuelsson; Bengt Långström
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- French
- Weight
- 111 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.798
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The synthesis of a ^11^C‐labelled methyl stannane, (5‐[^11^C]methyl‐1‐aza‐5‐stanna‐bicyclo[3.3.3]undecane (2)), and its use in palladium‐mediated Stille reactions to form [^11^C]C–C bonds are described. Stannane 2 was synthesized from iodo[^11^C]methane, 5‐chloro‐1‐aza‐5‐stanna‐bicyclo[3.3.3]undecane 1 and butyl lithium in 20–90% decay‐corrected radiochemical yield starting from iodo[^11^C]methane. Subsequent reaction with a series of substituted aryl and vinyl halides produced the corresponding [^11^C]methylated products 3–5 in up to 90% decay‐corrected radiochemical yield from the crude 2. The total synthesis time, including purification, was 25–30 min from end of radionuclide production. Copyright © 2003 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract The synthesis of a series of epoxy 5‐phenylmorphans is being explored in order to determine the conformational requirements of the phenolic ring in a phenylmorphan molecule that may be needed both for binding to a specific opioid receptor and for exhibiting opioid agonist or antagonist
## Abstract A convenient synthesis of [N‐methyl‐^11^C]‐3‐[(6‐dimethylamino)pyridin‐3‐yl]‐2,5‐dimethyl‐__N__,__N__‐dipropylpyrazolo[1,5‐a]pyrimidine‐7‐amine (R121920), a highly selective CRF~1~ antagonist has been developed as a potential PET ligand. 3 ‐ [(6 ‐ methylamino)pyridin ‐ 3 ‐ yl]‐2,5‐dimet